Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE
Recruiting
Phase 3
Interventional Study
Nocturnal Enuresis in Children
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 6 – 18
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 120 (estimated)
- Sponsor
- Mansoura University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to compare combination of Solifenacin and MIrabegron in treatment of primary mono-symptomatic nocturnal enuresis in children. It will also learn about the safety of that combination. The main questions it aims to answer are:
Does combination of Solifenacin and MIrabegron lower the number of wet nights? What medical problems do participants have when taking combi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Primary mono-symptomatic nocturnal enuresis -
Exclusion Criteria:
Bowel dysfunction Psychatric illness Respiratory sleep disorders
\-
Contacts